OVERVIEW

CVD is the leading cause of death in the US. Hypertension and diabetes are among the foremost risk factors for the development of CVD, stroke, peripheral artery disease, and heart attack. This program will provide an overview of recent advances that target the underlying pathophysiology of cardiovascular disease. The focus of the program will be on the new guidelines for hypertension, DM and CKD and will discuss the advances in pharmacotherapeutics in these fields.

TARGET AUDIENCE

Specialties - FAMILY MEDICINE, FAMILY MEDICINE - Geriatric Medicine, INTERNAL MEDICINE, INTERNAL MEDICINE - Advanced Heart Failure and Transplant Cardiology, INTERNAL MEDICINE - Cardiovascular Disease, INTERNAL MEDICINE - Clinical Cardiac Electrophysiology, INTERNAL MEDICINE - Endocrinology, Diabetes and Metabolism, INTERNAL MEDICINE - Geriatric Medicine, INTERNAL MEDICINE - Interventional Cardiology, INTERNAL MEDICINE - Nephrology, INTERNAL MEDICINE - Sports Medicine, OBSTETRICS AND GYNECOLOGY, OBSTETRICS AND GYNECOLOGY - Maternal and Fetal Medicine, PREVENTIVE MEDICINE - Clinical Informatics, PUBLIC HEALTH AND GENERAL PREVENTIVE MEDICINE

LEARNING OBJECTIVES

1. Select appropriate medications to reduce adverse cardiovascular outcomes in high-risk and vulnerable populations
2. Identify appropriate blood pressure goals and management in several special patient populations
3. Review the controversies regarding the appropriate treatment of, and management of, pregnant patients at risk for CVD.
4. Provide the best screening and treatment options for hypertension in young patients with hyperlipidemia
5. Apply appropriate pharmacologic and non-pharmacologic approaches to cardiovascular risk prevention

ACCREDIATION

In support of improving patient care, Penn Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

DESIGNATION OF CREDIT
Physicians: Penn Medicine designates this live activity for a maximum of 4.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For more information please visit the official event page.